These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5899511)

  • 21. Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma.
    Majewski S; Skopińska M; Błaszczyk M; Ryba M; Grieb P; Chorzelski T; Jabłońska S
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):33-4. PubMed ID: 7503631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of systemic scleroderma with fucidine with regard to some free amino acids contents before and after therapy.
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowska K; Mozdzanowski J
    Acta Derm Venereol; 1984; 64(3):267-70. PubMed ID: 6204494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hydrocortisone and cuprenil phonophoresis in the therapy of scleroderma].
    Dovzhanskaia VS
    Vestn Dermatol Venerol; 1980 Oct; (10):50-1. PubMed ID: 7003965
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP
    Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046
    [No Abstract]   [Full Text] [Related]  

  • 25. [Griseofulvin in the treatment of circumscribed scleroderma].
    Capusan I; Pop OM; Pop CS
    Dermatologica; 1966; 132(4):337-42. PubMed ID: 5958880
    [No Abstract]   [Full Text] [Related]  

  • 26. Avascular necrosis of the carpal scaphoid associated with progressive systemic sclerosis.
    Kawai H; Tsuyuguchi Y; Yonenobu K; Inoue A; Tada K
    Hand; 1983 Oct; 15(3):270-3. PubMed ID: 6642301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulse therapy in scleroderma.
    Vatwani V; Palta SC; Verma N; Pathak PR; Singh RP
    Indian Pediatr; 1994 Aug; 31(8):993-5. PubMed ID: 7883356
    [No Abstract]   [Full Text] [Related]  

  • 28. Nodular scleroderma: a report of 2 cases.
    Wriston CC; Rubin AI; Elenitsas R; Crawford GH
    Am J Dermatopathol; 2008 Aug; 30(4):385-8. PubMed ID: 18645312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Observations on the effect of anticoagulants in diffuse scleroderma. Preliminary report].
    Michalowski R; Kudejko T
    Pol Tyg Lek; 1965 Dec; 20(49):1865-6. PubMed ID: 5862129
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive systemic sclerosis and penicillamine.
    Rodnan GP
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of procaine, griseofulvin and chloroquine on skin perfusion in progressive scleroderma].
    Wiskemann A; Korff F
    Dermatol Wochenschr; 1967 Sep; 153(37):1033-7. PubMed ID: 5589729
    [No Abstract]   [Full Text] [Related]  

  • 33. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS; Gilgor RS; Allen LM; Duvic M
    Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microcirculatory disorders in systemic scleroderma treated with d-penicillamine].
    Nasonova VA; Alekberova ZS; Mach ES; Balabanova RM
    Klin Med (Mosk); 1981 Nov; 59(11):57-61. PubMed ID: 7321499
    [No Abstract]   [Full Text] [Related]  

  • 35. Small mouths ... Big problems? A review of scleroderma and its oral health implications.
    Albilia JB; Lam DK; Blanas N; Clokie CM; Sándor GK
    J Can Dent Assoc; 2007 Nov; 73(9):831-6. PubMed ID: 18028759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progressive systemic sclerosis with gastrointestinal manifestations].
    Lynggaard F; Mohammed SH; Schulze S; Ammitzbøll T
    Ugeskr Laeger; 1982 Sep; 144(39):2864-5. PubMed ID: 7179558
    [No Abstract]   [Full Text] [Related]  

  • 37. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma].
    Alekperov RT; Avdeev SN; Kotovskaia MA
    Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic trial with fucidin in systemic scleroderma].
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowski J; Mozdzanowska K
    Z Hautkr; 1984 Dec; 59(23):1611-9. PubMed ID: 6395525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The treatment of scleroderma with uropancreozymin].
    Kvícalová E; Obrtel J; Stáva Z; Svatos A
    Cesk Dermatol; 1966 Apr; 41(2):109-14. PubMed ID: 5943477
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of unithiol on collagen metabolism in systemic scleroderma].
    Pasieshvili LM
    Vopr Revm; 1980; (1):57-8. PubMed ID: 7385751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.